Literature DB >> 29440236

The consequences of patient charges for prescription drugs in Canada: a cross-sectional survey.

Michael R Law1, Lucy Cheng1, Ashra Kolhatkar1, Laurie J Goldsmith1, Steven G Morgan1, Anne M Holbrook1, Irfan A Dhalla1.   

Abstract

BACKGROUND: Many Canadians face substantial out-of-pocket charges for prescription drugs. Prior work suggests that this causes some patients to not take their medications as prescribed; however, we have little understanding of whether charges for prescription medicines lead patients to forego basic needs or to use more health care services. Our study aimed to quantify the consequences of patient charges for medicines in Canada.
METHODS: As part of the 2016 Canadian Community Health Survey, we designed and fielded cross-sectional questions to 28 091 Canadians regarding prescription drug affordability, consequent use of health care services and trade-offs with other expenditures. We calculated weighted population estimates and proportions, and used logistic regression to determine which patient characteristics were associated with these behaviours.
RESULTS: Overall, 5.5% (95% confidence interval 5.1%-6.0%) of Canadians reported being unable to afford 1 or more drugs in the prior year, representing 8.2% of those with at least 1 prescription. Drugs for mental health conditions were the most commonly reported drug class for cost-related nonadherence. About 303 000 Canadians had additional doctor visits, about 93 000 sought care in the emergency department, and about 26 000 were admitted to hospital at the population level. Many Canadians forewent basic needs such as food (about 730 000 people), heat (about 238 000) and other health care expenses (about 239 000) because of drug costs. These outcomes were more common among females, younger adults, Aboriginal peoples, those with poorer health status, those lacking drug insurance and those with lower income.
INTERPRETATION: Out-of-pocket charges for medicines for Canadians are associated with foregoing prescription drugs and other necessities as well as use of additional health care services. Changes to protect vulnerable populations from drug costs might reduce these negative outcomes. Copyright 2018, Joule Inc. or its licensors.

Entities:  

Year:  2018        PMID: 29440236      PMCID: PMC5878943          DOI: 10.9778/cmajo.20180008

Source DB:  PubMed          Journal:  CMAJ Open        ISSN: 2291-0026


  28 in total

1.  Access to primary care from the perspective of Aboriginal patients at an urban emergency department.

Authors:  Annette J Browne; Victoria L Smye; Patricia Rodney; Sannie Y Tang; Bill Mussell; John O'Neil
Journal:  Qual Health Res       Date:  2010-11-12

2.  The incidence and determinants of primary nonadherence with prescribed medication in primary care: a cohort study.

Authors:  Robyn Tamblyn; Tewodros Eguale; Allen Huang; Nancy Winslade; Pamela Doran
Journal:  Ann Intern Med       Date:  2014-04-01       Impact factor: 25.391

3.  Cost-related prescription nonadherence in the United States and Canada: a system-level comparison using the 2007 International Health Policy Survey in Seven Countries.

Authors:  Jae Kennedy; Steve Morgan
Journal:  Clin Ther       Date:  2009-01       Impact factor: 3.393

4.  Addressing cost-related barriers to prescription drug use in Canada.

Authors:  Karen L Tang; William A Ghali; Braden J Manns
Journal:  CMAJ       Date:  2013-09-16       Impact factor: 8.262

5.  The road to competitive generic drug prices in Canada.

Authors:  Michael R Law; Jillian Kratzer
Journal:  CMAJ       Date:  2012-11-19       Impact factor: 8.262

6.  We need to mandate drug cost transparency on electronic medical records.

Authors:  Iris Gorfinkel; Joel Lexchin
Journal:  CMAJ       Date:  2017-12-18       Impact factor: 8.262

7.  Variation in health services utilization among ethnic populations.

Authors:  Hude Quan; Andrew Fong; Carolyn De Coster; Jianli Wang; Richard Musto; Tom W Noseworthy; William A Ghali
Journal:  CMAJ       Date:  2006-03-14       Impact factor: 8.262

8.  Unfilled prescriptions of medicare beneficiaries: prevalence, reasons, and types of medicines prescribed.

Authors:  Jae Kennedy; Iulia Tuleu; Katherine Mackay
Journal:  J Manag Care Pharm       Date:  2008 Jul-Aug

9.  Coping with prescription medication costs: a cross-sectional look at strategies used and associations with the physical and psychosocial health of individuals with arthritis.

Authors:  Kathryn Remmes Martin; Jack Shreffler; Britta Schoster; Leigh F Callahan
Journal:  Ann Behav Med       Date:  2012-10

Review 10.  Improving access to medicines in urban, regional and rural Aboriginal communities--is expansion of Section 100 the answer?

Authors:  J Stoneman; S J Taylor
Journal:  Rural Remote Health       Date:  2007-06-22       Impact factor: 1.759

View more
  19 in total

1. 

Authors:  Iris Gorfinkel; Ahuva Brown; Joel R Lexchin
Journal:  Can Fam Physician       Date:  2020-10       Impact factor: 3.275

2.  Engaging physicians to prescribe more cost-effectively: Blueprint for change.

Authors:  Iris Gorfinkel; Ahuva Brown; Joel R Lexchin
Journal:  Can Fam Physician       Date:  2020-10       Impact factor: 3.275

3.  Drug coverage in Canada: gaps and opportunities.

Authors:  Fiona Clement; Katherine A Memedovich
Journal:  J Psychiatry Neurosci       Date:  2018-05       Impact factor: 6.186

4.  Prescription medication nonadherence associated with food insecurity: a population-based cross-sectional study.

Authors:  Fei Men; Craig Gundersen; Marcelo L Urquia; Valerie Tarasuk
Journal:  CMAJ Open       Date:  2019-09-23

5.  Income-related disparities in private prescription drug coverage in Canada.

Authors:  Talshyn Bolatova; Michael R Law
Journal:  CMAJ Open       Date:  2019-10-11

6.  After More Than 50 Years, Pharmacare (and Dental Care) are Coming to Canada.

Authors:  Joel Lexchin
Journal:  Int J Health Serv       Date:  2022-05-09       Impact factor: 1.851

7.  Patterns of borrowing to finance out-of-pocket prescription drug costs in Canada: a descriptive analysis.

Authors:  Ashra Kolhatkar; Lucy Cheng; Steven G Morgan; Laurie J Goldsmith; Irfan A Dhalla; Anne M Holbrook; Michael R Law
Journal:  CMAJ Open       Date:  2018-11-19

Review 8.  Pharmacare in Canada: The paediatric perspective.

Authors:  Tom McLaughlin; Geert 't Jong; Andrea Gilpin; Charlotte Moore Hepburn
Journal:  Paediatr Child Health       Date:  2020-03-13       Impact factor: 2.253

9.  Cost-related nonadherence to prescription medications in Canada: a scoping review.

Authors:  Shikha Gupta; Mary Ann McColl; Sara J Guilcher; Karen Smith
Journal:  Patient Prefer Adherence       Date:  2018-09-06       Impact factor: 2.711

Review 10.  Prescription drug coverage in Canada: a review of the economic, policy and political considerations for universal pharmacare.

Authors:  Jaden Brandt; Brenna Shearer; Steven G Morgan
Journal:  J Pharm Policy Pract       Date:  2018-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.